Arcadia Biosciences, Inc. (RKDA) › RevenueArcadia Biosciences, Inc. (RKDA) — RevenueAnnual figures by period end, from SEC filings.2017-12-31: $4.03M2018-12-31: $1.46M2019-12-31: $1.17M2020-12-31: $8.03M2021-12-31: $6.78M2022-12-31: $7.42M2023-12-31: $4.45M2024-12-31: $5.04M2025-12-31: $4.86M$4.86M2017-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$4.86M-3.7%2026-03-26From 2025-01-012024-12-31$5.04M+13.3%2026-03-26From 2024-01-012023-12-31$4.45M-40.0%2025-03-25From 2023-01-012022-12-31$7.42M+9.4%2024-03-28From 2022-01-012021-12-31$6.78M-15.6%2023-03-30From 2021-01-012020-12-31$8.03M+587.3%2022-03-31From 2020-01-012019-12-31$1.17M-20.2%2021-03-31From 2019-01-012018-12-31$1.46M-63.6%2020-03-25From 2018-01-012017-12-31$4.03M—2019-04-01From 2017-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)